Please assess the completion status of the following clinical trial:

Trial Title: Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Emergency~* Trauma patient admitted in participating trauma care centers~* Severe bleeding requiring transfusion with 4 units of red blood cells and 4 emergency plasma.~* Inclusion performed within the first 6 hours after trauma.~Exclusion Criteria:~* Patient taking anticoagulants~* Patients who have received hemostatic treatment during transport (tranexamic -acid excluded)~* Minor Patient~* Pregnant or breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Freezed-dried plasma (Type: EXPERIMENTAL): transfusion of 4 units of freezed dried plasma when available in patients at risk pf massive bleeding (transfusion of 4 red blood cells units in the first 6 hours after trauma)
- Fresh-frozen plasma (Type: ACTIVE_COMPARATOR): transfusion of 4 units of fresh frozen plasma when available in patients at risk pf massive bleeding (transfusion of 4 red blood cells units in the first 6 hours after trauma)

Based on this trial design, predict the completion outcome and termination type (if applicable).